Home ›
Trademark Categories ›
Pharmaceuticals ›
2000 ›
VI ›
VIVAIR
Trademark search for:
VIVAIR
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2004-07-13 — Application filed
2004-07-21 — Application filed
2005-02-16 — Approved for pub - principal register
2005-02-16 — Assigned to examiner
2005-02-18 — Assigned to lie
2005-02-22 — Law office publication review completed
2005-05-18 — Notice of publication
2005-06-07 — Published for opposition
2005-08-30 — Noa mailed - sou required from applicant
2006-02-14 — Assigned to examiner
2006-02-23 — Sou teas extension received
2006-02-23 — Sou extension 1 filed
2006-03-10 — Sou extension 1 granted
2006-08-15 — Sou teas extension received
2006-08-15 — Sou extension 2 filed
2006-08-15 — Sou extension 2 granted
2007-01-16 — Sou teas extension received
2007-01-16 — Sou extension 3 filed
2007-01-16 — Sou extension 3 granted
2007-07-25 — Sou teas extension received
2007-07-25 — Sou extension 4 granted
2007-07-25 — Sou extension 4 filed
2008-01-07 — Sou teas extension received
2008-01-07 — Sou extension 5 filed
2008-01-07 — Sou extension 5 granted
2008-10-27 — Application abandoned
2008-10-27 — Application abandoned
2008-10-27 — Final status recorded
Owner Information
Glaxo Group Limited
Greenford, Middlesex GB
Glaxo Group Limited
Greenford, Middlesex GB
Correspondent
Maribeth Day Case GLAXOSMITHKLINE CIP Trademarks - MAI.B-475D 5 Moore Drive RESEARCH TRIANGLE PARK, NC 27709
Filing Details
Filing Date:
2004-07-13
Status Date:
2008-10-27
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.